CRISPR-induced RASGAP deficiencies in colorectal cancer organoids reveal that only loss of NF1 promotes resistance to EGFR inhibition. - Post JB; Hami N; Mertens AEE; Elfrink S; Bos JL; Snippert HJG (Oncotarget, 2019)